Login to Your Account



Financings Roundup

Aduro Raises $19.25M for CRS-207 Phase II Trial

By Tom Wall


Thursday, April 21, 2011
Aduro BioTech raised $19.25 million in a Series B equity financing backed by a combination of current investors and Morningside Ventures.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription